Research on the cohort from the first open-label psilocybin study for treatment-resistant depression found increased amygdala responses to emotional stimuli, that changes in amygdala connectivity predict some clinical outcomes, and that patients show increased brain response to music stimuli following treatment.

Authors

• Person: Not available Organization: Nature
  Neuroimaging in psychedelic drug development: past, present, and ...

Sources

• Neuroimaging in psychedelic drug development: past, present, and ... www.nature.com Nature via serper

Referenced by nodes (3)

• psilocybin concept
• treatment-resistant depression concept
• amygdala concept